|
|
|
Insider
Information: |
Cross Alexander D |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
64,335 |
|
Indirect Shares
|
94,867 |
|
|
Direct
Value |
$2,266,390 |
|
|
Indirect Value
|
$516,446 |
|
|
Total
Shares |
159,202 |
|
|
Total
Value |
$2,782,836 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2006-03-01 |
26,335 |
2006-03-01 |
6,001 |
Premium* |
|
Adhera Therapeutics, Inc |
ATRX |
Director |
2008-05-14 |
38,000 |
|
0 |
Premium* |
|
Atossa Genetics Inc |
ATOS |
Director |
|
0 |
2013-05-15 |
88,866 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2004-01-12 |
4 |
OE |
$5.81 |
$125,282 |
D/D |
16,237 |
24,494 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2004-05-25 |
4 |
AS |
$19.00 |
$38,000 |
I/I |
(2,000) |
10,001 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2004-05-26 |
4 |
AS |
$20.00 |
$40,000 |
I/I |
(2,000) |
8,001 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2004-05-26 |
4 |
AS |
$21.00 |
$21,000 |
I/I |
(1,000) |
7,001 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2004-05-27 |
4 |
AS |
$21.00 |
$21,000 |
I/I |
(1,000) |
6,001 |
|
- |
|
ATRX |
Adhera Therapeutics, Inc |
Director |
|
2005-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,500 |
17,500 |
|
- |
|
ATRX |
Adhera Therapeutics, Inc |
Director |
|
2005-07-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2006-03-01 |
4 |
OE |
$3.73 |
$6,872 |
D/D |
1,841 |
26,335 |
|
- |
|
ATRX |
Adhera Therapeutics, Inc |
Director |
|
2006-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
22,500 |
|
- |
|
ATRX |
Adhera Therapeutics, Inc |
Director |
|
2007-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
28,000 |
0 |
- |
|
ATRX |
Adhera Therapeutics, Inc |
Director |
|
2008-05-14 |
4 |
A |
$1.26 |
$12,635 |
D/D |
10,000 |
38,000 |
0 |
- |
|
ATOS |
Atossa Genetics Inc |
Director |
|
2012-11-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
88,366 |
|
- |
|
ATOS |
Atossa Genetics Inc |
Director |
|
2013-05-15 |
4 |
B |
$5.49 |
$2,745 |
I/I |
500 |
88,866 |
2.1 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|